Dr. Graff will lead IMV’s research to continue the expansion of DPX- based immuno-oncology pipeline and the development of a comprehensive translational strategy to optimize clinical success Industry veteran Stanley Frankel, M.D. to advise on clinical development DARTMOUTH, Nova Scotia (BUSINESS WIRE) $IMV #Delive.
Dr. Graff will lead IMV s research to continue the expansion of DPX- based immuno-oncology pipeline and the development of a comprehensive translational strategy to optimize. | June 9, 2021
A new study is showing improved survival in men with advanced prostate cancer from an experimental drug that delivers radiation directly to tumor cells.